Lvw Advisors, LLC Cytokinetics Inc Transaction History
Lvw Advisors, LLC
- $916 Million
- Q3 2025
A detailed history of Lvw Advisors, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Lvw Advisors, LLC holds 3,982 shares of CYTK stock, worth $253,215. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,982Holding current value
$253,215% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding CYTK
# of Institutions
385Shares Held
129MCall Options Held
3.62MPut Options Held
1.14M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$1.12 Billion0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$933 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$762 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$498 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$405 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.99B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...